Back to search

Article

A new concept on anti-SARS-CoV-2 vaccines: strong CD8 <sup>+</sup> T-cell immune response in both spleen and lung induced in mice by endogenously engineered extracellular vesicles

2020-12-18

Abstract excerpt

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is spreading rapidly in the absence of validated tools to control the growing epidemic besides social distancing and masks. Many efforts are ongoing for the development of vaccines against SARS-CoV-2 since there is an imminent need to develop effective interventions for controlling and preventing SARS-CoV-2 spread. Essentially all vaccines in most advanced...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cd725a9e-f447-5b1c-8302-81e6a24ffe37
DOI
10.1101/2020.12.18.423420
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A new concept on anti-SARS-CoV-2 vaccines: strong CD8 <sup>+</sup> T-cell immune response in both spleen and lung induced in mice by endogenously engineered extracellular vesiclesDOI 10.1101/2020.12.18.423420
Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in miceSemantic proximity
Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in MiceSemantic proximity
Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2Semantic proximity
Induction of SARS-CoV-2 N-specific CD8 <sup>+</sup> T cell immunity in lungs by engineered extracellular vesicles associates with strongly impaired viral replicationSemantic proximity
Virus-Induced CD8+ T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 PandemicSemantic proximity
Induction of SARS-CoV-2 N-specific CD8+ T cell immunity in lungs by engineered extracellular vesicles associates with strongly impaired viral replicationSemantic proximity
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccineSemantic proximity
Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteinsSemantic proximity
Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2Semantic proximity
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsSemantic proximity
Nanocell COVID-19 vaccine elicits iNKT-licensed dendritic cells to produce high affinity antibodies neutralizing Variants of ConcernSemantic proximity
Next‐Generation Vaccines: Nanovaccines in the Fight against SARS‐CoV‐2 Virus and beyond SARS‐CoV‐2Semantic proximity
Select a neighboring publication to make it the new centre.